桂林三金：生物制药是公司一体两翼战略的重要组成部分

Core Viewpoint - The company emphasizes the importance of biopharmaceuticals as a key component of its "one body, two wings" strategy, focusing on optimizing its R&D pipeline and enhancing research efficiency [2] Group 1 - The company plans to continuously optimize its R&D pipeline [2] - The company aims to adjust its personnel structure to improve research efficiency [2] - The company is committed to building its core competitiveness in the biopharmaceutical sector [2]